NCT03753659 2026-03-23
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
National Institutes of Health Clinical Center (CC)
National Taiwan University Hospital
Sir Run Run Shaw Hospital
University of Utah
The First People's Hospital of Changzhou
National Cancer Institute (NCI)
St. Joseph's Hospital, Florida